Mechanism-first science for a body that's finally being heard.
The GLP-1 era taught millions of people to pay attention to their metabolic signals. MetIQ is building the science, formulations, and standards to answer them — honestly, and for the long term.
The awareness is real. The system to act on it isn't — yet.
More than 50 million people worldwide are on GLP-1 medications, and tens of millions more are looking for safe, accessible ways to support the same metabolic signaling — often after stepping off a prescription with nowhere credible to land.
MetIQ exists to close that gap: real mechanism instead of trends, evidence instead of hype, and a body of science built to meet people wherever they are.
The Triple Metabolic System
MetIQ's first formulation: a patent-pending, non-drug, non-stimulant daily supplement built on coordinated support for three metabolic receptors — not one.
Published research, not marketing claims.
MetIQ's science is published before it's sold — rigorously sourced, citation-backed references that give researchers, clinicians, and informed readers a single map of the field.
Be first to know when GLP-III launches.
No spam — just launch news, the Scientific Authority Series, and early access.